| __timestamp | Alnylam Pharmaceuticals, Inc. | argenx SE |
|---|---|---|
| Wednesday, January 1, 2014 | 50561000 | 4579319.93 |
| Thursday, January 1, 2015 | 41097000 | 7504448.39 |
| Friday, January 1, 2016 | 47159000 | 15466459 |
| Sunday, January 1, 2017 | 89912000 | 43793829 |
| Monday, January 1, 2018 | 74908000 | 24564806 |
| Tuesday, January 1, 2019 | 219750000 | 78116087 |
| Wednesday, January 1, 2020 | 492853000 | 44848173 |
| Friday, January 1, 2021 | 844287000 | 497277000 |
| Saturday, January 1, 2022 | 1037418000 | 410746000 |
| Sunday, January 1, 2023 | 1828292000 | 1226316000 |
| Monday, January 1, 2024 | 2248243000 |
Infusing magic into the data realm
In the competitive landscape of biotechnology, revenue growth is a key indicator of success. Over the past decade, Alnylam Pharmaceuticals, Inc. and Argenx SE have been at the forefront of innovation, each striving to lead in annual revenue. From 2014 to 2023, Alnylam Pharmaceuticals has consistently outpaced Argenx SE, with a remarkable 3,500% increase in revenue, peaking at $1.83 billion in 2023. Meanwhile, Argenx SE has shown impressive growth, achieving a 26,600% increase, reaching $1.23 billion in the same year.
Alnylam's revenue surged notably in 2020, marking a pivotal year with a 125% increase from the previous year. Argenx, on the other hand, saw its most significant leap in 2021, with a 1,000% increase from 2020. This data highlights the dynamic nature of the biotech industry, where innovation and strategic investments drive financial success.
AbbVie Inc. vs argenx SE: Examining Key Revenue Metrics
Who Generates More Revenue? Takeda Pharmaceutical Company Limited or Alnylam Pharmaceuticals, Inc.
argenx SE or Exelixis, Inc.: Who Leads in Yearly Revenue?
Comparing Revenue Performance: argenx SE or Vericel Corporation?
Revenue Showdown: argenx SE vs MiMedx Group, Inc.
Comparing Revenue Performance: Alnylam Pharmaceuticals, Inc. or Teva Pharmaceutical Industries Limited?
Annual Revenue Comparison: Alnylam Pharmaceuticals, Inc. vs Catalent, Inc.
Comparing Revenue Performance: Alnylam Pharmaceuticals, Inc. or Ionis Pharmaceuticals, Inc.?
Revenue Showdown: Alnylam Pharmaceuticals, Inc. vs Perrigo Company plc
Alnylam Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.: Annual Revenue Growth Compared
Revenue Insights: Alnylam Pharmaceuticals, Inc. and Celldex Therapeutics, Inc. Performance Compared
Comparing Revenue Performance: Alnylam Pharmaceuticals, Inc. or MiMedx Group, Inc.?